Terrosa

Terrosa Caution For Usage

teriparatide

Manufacturer:

Alvogen

Distributor:

Zuellig Pharma
Full Prescribing Info
Caution For Usage
Incompatibilities: In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.
Special precautions for disposal <and other handling>: Terrosa 20 μg/80 μL solution for injection is supplied in a cartridge. Terrosa 20 μg/80 μL solution for injection cartridges are to be used in Terrosa Pen reusable, multidose pen device exclusively and must not be used with any other pen. No needles are supplied with this medicinal product.
Each cartridge and pen should be used by only one patient. The pen can be used with compatible pen needles. These are listed in the instructed for use for the pen. A new, sterile pen needle must be used for every injection.
The expiry date on the cartridge label must always be checked before inserting the cartridge into Terrosa Pen. To avoid medication errors make sure that the date when starting to use a new cartridge is at least 28 days before its expiry date.
Before using the pen device for the first time, the patient should read and understand the instructions on how to use the pen which are provided with the pen.
After each injection, the pen should be returned to the refrigerator. After the first use, the cartridge should not be removed from the pen during the 28 days of usage.
Terrosa 20 μg/80 μL solution for injection must not be transferred to a syringe.
Empty cartridges must not be refilled.
Terrosa 20 μg/80 μL solution for injection should not be used if the solution is cloudy, coloured or contains visible particles.
Any unused product or waste material should be disposed of in accordance with local requirements.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in